BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Tangent Medical Technologies, Inc. Welcomes Jeff Williams as CEO


8/19/2011 6:45:58 AM

ANN ARBOR, Mich.--(BUSINESS WIRE)-- Tangent Medical Technologies, Inc., a development stage medical device company focused on next generation intravenous access systems, is pleased to announce Jeffrey S. Williams has joined the company as its Chief Executive Officer. Additionally, Mr. Williams will serve as Chairman of the board of directors.

Previously, Mr. Williams had been President & CEO of Accuri Cytometers, a life science instrument and clinical diagnostic company, from January 2010 until its sale for $205 million in March 2011. While at Accuri, he oversaw revenue growth of 65% year-over-year, the development of a clinical system, and the achievement of positive cash flow. Prior to Accuri, Mr. Williams had been President & CEO of HandyLab, Inc., a molecular diagnostic company, since 2004. At HandyLab, he led the growth and venture financing of the company, ultimately resulting in its sale for $275 million in November 2009. Previously, Mr. Williams was President & CEO of Genomic Solutions Inc., a life science products company he co-founded in 1997. He led Genomic Solutions through a period of rapid growth culminating in an IPO on NASDAQ in 2000 and merger with Harvard Biosciences, Inc. in late 2002. Prior to Genomic Solutions, Mr. Williams held various executive and management level positions in several bioscience companies, including IRIS and Boehringer Mannheim. He received a BS in Biology from Alma College and an MBA from The University of Michigan. In addition to Tangent, Mr. Williams is a member of several boards, including Life Magnetics, where he serves as Executive Chairman.

Mr. Williams succeeds Hank Brown, founding investor and interim CEO since Tangent’s inception in July 2009. Mr. Brown noted, “I’m convinced that with Jeff’s dedicated leadership and drive Tangent will be in a great position to execute its business plan to advance blood containment and catheter securement technology in the peripheral intravenous catheter market.” Brown, who will continue to serve on Tangent’s board of directors, concluded, “It’s fantastic that the Tangent team was able to attract such a significant and accomplished CEO. As an added bonus, he is local and well known in the community.”

“Tangent shares a lot of similarities with HandyLab and Accuri,” said Williams. “All three companies target multi-billion dollar markets with revolutionary products that offer many advantages over the competition. The one major difference is Tangent will have the added advantage of generating nearly one hundred percent of its revenues from recurring consumable sales.” Williams continued, “The team has made tremendous progress with product development in a very short amount of time and with little capital. I am confident that we will successfully launch our initial product into the billion-dollar-plus IV catheter market within the next year.”

About Tangent Medical Technologies, Inc.

Tangent Medical, a development stage medical device company, was founded in Ann Arbor, Michigan in 2009 based on technology exclusively licensed from the University of Michigan’s Medical Innovation Center. The company’s mission is to improve infusion therapy safety for patients and healthcare workers with its proprietary, intravenous (IV) catheters and associated products. Tangent is led by an experienced, successful management team and the original inventors of the technology. The company expects to begin generating commercial revenues from its lead product, the NovaCath™ peripheral IV system with integrated stabilization and blood containment, in 2012. www.tangentmedical.com

Contact:

Larry EilerEiler Communications734-646-6593larry@eilerpr.comorElyse KemmererDirector of Business DevelopmentTangent Medical Technologies, Inc.(734) 330-2668elyse@tangentmedical.com58 Parkland Plaza, Suite 200Ann Arbor, MI 48103


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->